Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Testing effectiveness (Phase 2)UnknownNCT04395456
What this trial is testing

The C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

Who this might be right for
Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Amyndas Pharmaceuticals S.A. 144
Not applicableStudy completedNCT04457505
What this trial is testing

One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeSevere PneumoniaRespiratory Failure
Consorcio Centro de Investigación Biomédica en Red (CIBER) 8,500
Not applicableStudy completedNCT05012267
What this trial is testing

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

Who this might be right for
Ards
Ignacio Saez de la Fuente 61
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Not applicableUnknownNCT04935450
What this trial is testing

Pulmonary Inflammation in COVID-19 ARDS

Who this might be right for
ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2COVID-19 Acute Respiratory Distress Syndrome
Hospital Universitario Ramon y Cajal 25
Post-approval studies (Phase 4)WithdrawnNCT04334629
What this trial is testing

LIBERATE Trial in COVID-19

Who this might be right for
CoronavirusRespiratory Distress SyndromeSARS-CoV Infection
King's College London
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Testing effectiveness (Phase 2)UnknownNCT04416139
What this trial is testing

Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19

Who this might be right for
Covid 19
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 10
Testing effectiveness (Phase 2)Ended earlyNCT04771000
What this trial is testing

Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19

Who this might be right for
Covid19Hypoxemia
Noorik Biopharmaceuticals AG 88
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Not applicableStudy completedNCT04922814
What this trial is testing

Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeSedation ComplicationICU Acquired Weakness
Assiut University 40
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50